Jeremy Springhorn is the founder of Nido Biosciences. Nido Biosciences has raised $109M in total funding. Latest round: Series B.
Jeremy Springhorn is the Chief Executive Officer of Nido Biosciences, a clinical-stage company that developed precision medicines for severe neurological diseases. He helped lead the company’s financing efforts, which raised $109 million, before it later wound down after its lead program underperformed in a midstage study.
Full founder directory · Investor directory · Company funding database · Fundraising library